Work

In vivo programming of dual-targeted CAR-T cells facilitates vascular disruption and T-cell infiltration in solid tumors

Year: 2026
Type: article
Abstract: T-cell therapies for solid tumors are restricted by abnormal tumor vasculature, which creates structural and immunological barriers to infiltration. Here we report a programmable mRNA lipid nanoparticle (LNP) platform that orchestrates a division-of-labor immune response in vivo. By modulating the LNP nano-bio interface through 10% 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) doping and indirect IgG-based anti-CD5 tethering, we achieve selective and efficient transfection of endogenous splenic T cells. This platform simultaneously generates two complementary chimeric antigen receptor (CAR)-T populations: a vascular endothelial growth factor receptor 2 (VEGFR2)-directed subset that transiently remodels the tumor endothelium, and a tumor-antigen-directed subset that executes cytotoxic clearance. Mechanistic analyses reveal that focal endothelial disruption creates a permissive window for the infiltration, expansion, and activation of tumor-directed CAR-T cells. In refractory melanoma and colorectal carcinoma models in female mice, this dual-programming strategy achieves superior tumor control and drives tumor regression while reducing systemic toxicity. By bypassing ex vivo manufacturing, this approach provides a scalable and host-directed strategy to breach infiltrative barriers in solid-tumor immunotherapy.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $6,990
OpenAlex ID: W7236784172
FWCI:
Cites: 34
Cited by:
Related to: 10